# Glucose, Insulin, and Diabetes ILG — Phase 3 Validation

## Scope

Phase 3 makes Compare mode functional without beginning Phase 4. Guided mode, the 12-step source data, the qualitative physiology model, and the StudyOS visual system remain in place.

## Implementation summary

- One synchronized 12-checkpoint timeline controls all three conditions.
- Normal, Type 1 diabetes, and Type 2 diabetes appear as aligned condition cards at every checkpoint.
- Each comparison view includes shared physiology, key divergence, most-diverged condition, clinical significance, and the next expected difference.
- Seven physiology indicators appear in aligned rows: blood glucose, insulin, glucagon, tissue glucose uptake, hepatic glucose output, urinary glucose, and ketones.
- Step-change arrows compare the current checkpoint with the checkpoint viewed immediately before it.
- Separate relation badges compare Type 1 and Type 2 with Normal at the same checkpoint.
- Basic, Organ, and Cellular explanations work in Compare mode.
- Normal remains the explicit reference condition.

## Sparse comparison refinement

Compare mode now treats Type 1 and Type 2 as difference overlays against the complete Normal reference.

- Normal continues to show its full Main event, Trigger, Next, complexity explanation, and prior-step change.
- Disease cards omit Main event, Trigger, Next, and complexity fields when their content matches Normal.
- Disease cards retain only substantive condition-specific fields, including the existing “Why it differs” teaching point where supplied by the pathway data.
- A disease card with no remaining difference displays one subdued, accessible no-divergence message instead of duplicated Normal content.
- Each physiology row always shows the Normal value.
- A disease physiology value is visually omitted when it matches Normal. Its aligned grid position remains available for scanning, and screen-reader text states that the condition matches Normal for that indicator.
- Disease physiology cells that differ from Normal remain visible and retain their higher/lower/delayed-recovery highlighting.

## Derived comparison logic

The interface derives comparison content from the existing three-condition pathway data. It does not maintain a duplicate comparison dataset.

- **Shared physiology:** the Normal event plus indicators whose values match across all three conditions.
- **Key divergence:** indicators that differ from Normal at the current checkpoint.
- **Most diverged:** the condition with the greatest summed ordinal distance from Normal across the seven indicators.
- **Step-change arrow:** the direction from the immediately preceding physiological checkpoint to the current checkpoint for that same condition.
- **Condition badge:** the direction and meaning of the condition's difference from Normal at the current checkpoint.
- **Timeline marker:** `similar` when no indicator differs; `hormonal` for insulin/glucagon-only differences; `renal` when urinary glucose differs; `metabolic` for tissue uptake or hepatic output differences; otherwise `tissue`.

This separation prevents an increase over time from being confused with a value that is higher than Normal.

## Twelve-checkpoint browser audit

Each checkpoint was opened directly from the shared timeline in Compare mode.

| Step | Checkpoint | Three condition cards | Seven metric rows | Five summary elements | Single active timeline point | Horizontal overflow |
|---:|---|:---:|:---:|:---:|:---:|:---:|
| 1 | Meal | Pass | Pass | Pass | Pass | None |
| 2 | Mouth | Pass | Pass | Pass | Pass | None |
| 3 | Stomach | Pass | Pass | Pass | Pass | None |
| 4 | Small Intestine | Pass | Pass | Pass | Pass | None |
| 5 | Portal Blood | Pass | Pass | Pass | Pass | None |
| 6 | Liver | Pass | Pass | Pass | Pass | None |
| 7 | Pancreas | Pass | Pass | Pass | Pass | None |
| 8 | Insulin Signal | Pass | Pass | Pass | Pass | None |
| 9 | Muscle and Adipose Tissue | Pass | Pass | Pass | Pass | None |
| 10 | Blood Glucose Returns Toward Baseline | Pass | Pass | Pass | Pass | None |
| 11 | Fasting and Glucagon | Pass | Pass | Pass | Pass | None |
| 12 | Kidney and Urine | Pass | Pass | Pass | Pass | None |

## Interaction validation

- **Direct timeline navigation:** Passed for all 12 checkpoints.
- **Next:** Passed; Step 3 → Step 4 displayed rising blood-glucose arrows for all three conditions.
- **Previous:** Passed; arriving at Step 4 from Step 5 produces the same Step 3 → Step 4 physiology comparison as forward or direct navigation.
- **Restart Pathway:** Passed; returned to Step 1 and disabled Previous.
- **Mode retention:** Passed; switching Compare → Guided → Compare retained Step 7 and Cellular complexity.
- **Complexity:** Passed at representative early, middle, and late checkpoints for Basic, Organ, and Cellular content.
- **Condition controls:** Passed; all three are visibly included and disabled as individual selectors during Compare, then return to normal Guided selection behavior.
- **Normal reference:** Passed; Normal is labeled as the reference and receives a neutral reference badge.
- **Future modes:** Explore and Challenge still show their later-phase notices; Phase 4 behavior was not added.

## Sparse-rendering browser audit

All 36 Compare combinations—12 checkpoints at Basic, Organ, and Cellular complexity—were tested after the sparse-rendering refinement.

- Every view retained seven visible Normal reference cells.
- Every view retained fourteen aligned disease positions divided correctly between visible difference cells and visually omitted match placeholders.
- No tested view produced horizontal overflow.
- Disease complexity explanations appeared only when their selected-level content differed from Normal.
- The accessible snapshot explicitly reported omitted values as matching Normal.

Representative behavior:

| Checkpoint | Complexity | Visible disease physiology differences | Hidden disease matches | Disease complexity duplicates |
|---|---|---:|---:|---:|
| Step 1 · Meal | Basic | 1 | 13 | 0 |
| Step 6 · Liver | Organ | 6 | 8 | 0 duplicated; both condition-specific explanations shown |
| Step 12 · Kidney and Urine | Cellular | 12 | 2 | 0 duplicated; both condition-specific explanations shown |

This confirms that early views are substantially quieter, middle views introduce only the emerging differences, and late views preserve the larger set of clinically meaningful divergences.

## Accessibility and presentation

- Timeline buttons include checkpoint names and derived divergence descriptions.
- The active checkpoint uses `aria-current="step"`.
- Comparison cards and physiology groups use semantic regions and headings.
- Each physiology reading includes screen-reader text that states its current level, change from the preceding physiological checkpoint, and relationship to Normal.
- Arrow meaning is not color-only; arrows are paired with accessible increase/decrease language.
- Condition difference is not expressed by arrow alone and remains a separate textual badge.
- Existing focus styling, keyboard-native buttons, and reduced-motion behavior remain intact.
- Live browser inspection at the available desktop/laptop viewport found no horizontal overflow. Responsive CSS changes the three-card grid to two columns and then one column, and stacks metric rows at the established tablet/mobile breakpoints.

## Regression checks

- Guided mode still renders the existing focused previous/current/next journey and right-side physiology panel.
- Compare hides only the redundant Guided physiology aside and restores it on return to Guided.
- Existing condition, mode, complexity, Previous, Next, and Restart controls remain functional.
- JavaScript syntax checks passed for `glucose-pathway.js` and `pathway-data.js`.
- Browser console returned no errors.
- The document reported no horizontal overflow throughout the 12-step Compare sweep.
- Guided mode was rechecked after sparse rendering: the focused pathway retained one active step, the expected previous/current/next subset, the full detail explanation, and the right-side physiology panel.

## Guided physiology-change refinement

Guided physiology now separates qualitative level from direction of change.

- Display levels are restricted to `None`, `Very low`, `Low`, `Normal`, `Elevated`, and `High`.
- `Rising`, `Falling`, and `Returning toward normal` are no longer stored or displayed as physiology levels.
- Every direction is derived from the current checkpoint and its immediately preceding pathway checkpoint. Step 1 uses its own baseline and therefore displays neutral arrows.
- The panel shows the current level followed by `↑`, `↓`, or `→` for increased, decreased, or unchanged.
- “What changed this step?” uses physiological sentences rather than raw level-pair output.
- Complexity strips now read `Key takeaway`, `Organ-level takeaway`, or `Cellular takeaway`.

Validation covered all 12 steps in Normal, Type 1 diabetes, and Type 2 diabetes—36 Guided condition/checkpoint combinations. Every displayed level belonged to the defined level scale, every arrow matched the immediately preceding checkpoint, no trend word appeared as a displayed level, no horizontal overflow occurred, and the browser console remained clear.

Step 4 was reached three ways: forward with Next, directly from the timeline after viewing Step 9, and backward from Step 5. All three routes produced the same result: blood glucose `Elevated ↑`, all unchanged indicators with `→`, and the same plain-language change summary.

## Result

**Pass.** Phase 3 Compare mode is functional across all conditions, checkpoints, and complexity levels. Phase 4 was not started.
